Combining Prostate‐Specific Antigen Density With PI‐RADS to Improve the Detection of Clinically Significant Prostate Cancer at MRI/TRUS Fusion‐Targeted Re‐Biopsy
Combining PSAD with PI-RADS improved risk stratification for csPCa in men who underwent MRI/TRUS fusion re-biopsies, while systematic biopsies added diagnostic value. These findings support individualized evidence-based re-biopsy strategies.
Authors
- Yuki Kohada (ORCID: https://orcid.org/0000-0002-6510-7461)
- Yukiko Honda (ORCID: https://orcid.org/0000-0002-2291-0502)
- Naoyuki Kitamura (ORCID: https://orcid.org/0000-0002-0422-1519)
- S Miyamoto
- Keisuke Hieda (ORCID: https://orcid.org/0000-0001-5182-8666)
- Akihiro Goriki (ORCID: https://orcid.org/0000-0002-5262-8129)
- Ryo Tasaka
- Keisuke Goto (ORCID: https://orcid.org/0000-0002-3580-1401)
- Hiroyuki Kitano (ORCID: https://orcid.org/0000-0002-4756-2356)
- Yuko Ono (ORCID: https://orcid.org/0000-0003-2044-1076)
- T. Hayashi
- Nobuyuki Hinata
- Yukio Takeshima
- Shinsaku Tasaka
- Masao Kato
- Yohei Sekino
- Kohei Kobatake
Institutions
- Hiroshima University (JP)
- Hiroshima General Hospital (JP)
Publication Details
- Journal
- The Prostate
- Published
- 2025-12-23
- DOI
- https://doi.org/10.1002/pros.70117
- Citations
- 1
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52